NRXS·64134X201·US·equity·Healthcare - Biotechnology-13D/G
NRXS (NEURAXIS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($689,248), MARSHALL WACE, LLP ($582,343), RENAISSANCE TECHNOLOGIES LLC ($569,460). Net institutional sentiment: Mixed.
See how NRXS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer